The SOX4/miR-17-92/RB1 Axis Promotes Prostate Cancer Progression

Although androgen-deprivation treatment (ADT) is the main treatment for advanced prostate cancer (PCa), it eventually fails. This failure invariably leads to castration-resistant prostate cancer (CRPC) and the development of the neuroendocrine (NE) phenotype. The molecular basis for PCa progression...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neoplasia
Glavni autori: Liu, Hui, Wu, Zhen, Zhou, Haibin, Cai, Wenjie, Li, Xinjun, Hu, Jing, Gao, Lin, Feng, Tingting, Wang, Lin, Peng, Xijia, Qi, Mei, liu, Long, Han, Bo
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press 2019
Teme:
Original article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593351/
https://ncbi.nlm.nih.gov/pubmed/31238254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2019.05.007
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items